Nuclear export of adenovirus E4orf6 protein is necessary for its ability to antagonize apoptotic activity of BH3-only proteins

Oncogene

Volumn 22, Issue 44, 2003, Pages 6919-6927

  Aoyagi, Mariko ^a   Higashino, Fumihiro ^a   Yasuda, Motoaki ^a   Takahashi, Akiko ^a   Sawada, Yukiharu ^b   Totsuka, Yasunori ^a   Kohgo, Takao ^a   Sano, Hidehiko ^a   Kobayashi, Masanobu ^c   Shindoh, Masanobu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO INSTITUTE OF PUBLIC HEALTH   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Adenovirus; BH 3 only protein; Bik; BNIP3; E4orf6; Nuclear export

Indexed keywords

CELL PROTEIN; PROTEIN BCL 2; PROTEIN BIK; PROTEIN BNIP3; PROTEIN P53; PROTEIN P73; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL STRAIN COS1; CELLULAR DISTRIBUTION; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; MALIGNANT TRANSFORMATION; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; VIRUS CARCINOGENESIS; VIRUS CELL TRANSFORMATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ADENOVIRUS E4 PROTEINS; AMINO ACID MOTIFS; AMINO ACID SUBSTITUTION; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL NUCLEUS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CONSENSUS SEQUENCE; CONSERVED SEQUENCE; COS CELLS; MEMBRANE POTENTIALS; MEMBRANE PROTEINS; MITOCHONDRIA; MUTAGENESIS, SITE-DIRECTED; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; PROTEINS; PROTO-ONCOGENE PROTEINS; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS; TUMOR SUPPRESSOR PROTEINS;

ADENOVIRIDAE; ANIMALIA; MURINAE;

EID: 0242406716     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206743     Document Type: Article

References (43)

1. Boyd JM, Gallo GJ, Elangovan B, Houghton AB, Malstron S, Avery BJ, Ebb RG, Subramanian T, Chittenden T, Luts RJ and Chinnadurai G. (1995). Oncogene, 11, 1921-1928.
2. Boyd JM, Malstrom S, Subramanian T, Venkatesh LK, Schaeper U, Elangovan B, D'Sa-Eipper C and Chinnanurai G. (1994). Cell, 19, 341-351.
3. Chandar N, Billig B, McMaster J and Nozak J. (1992). Br. J. Cancer, 65, 208-214.
4. Chen G, Ray R, Dubik D, Shi L, Cizeau J, Bleackley RC, Saxena S, Gietz RD and Greenberg AH. (1997). J. Exp. Med., 186, 1975-1983.
5. Cizeau J, Ray R, Chen G, Gietz RD and Greenberg AH. (2000). Oncogene, 19, 5453-5463.
6. Dobbelstein M, Roth J, Kimberly WT, Levine AJ and Shenk T. (1997). EMBO J., 16, 4276-4284.
7. Dobner T, Horikoshi N, Rubenwolf S and Shenk T. (1996). Science, 272, 1470-1473.
8. Dosch T, Horn F, Schneider G, Kratzer F, Dobner T, Hauber J and Stauber RH. (2001). J. Virol., 75, 5677-5683.
9. Fischer N, Voss MD, Mueller-Lantzsch N and Grasser FA. (1999). FEBS Lett., 447, 311-314.
10. Goodrum FD, Shenk T and Ornelles DA. (1996). J. Virol., 70, 6323-6335.
11. Green DR and Reed JC. (1998). Science, 281, 1309-1312.
12. Gross A, McDonnell JM and Korsmeyer SJ. (1999). Genes Dev., 13, 1899-1911.
13. Halbert DN, Cutt JR and Shenk T. (1985). J. Virol., 56, 250-257.
14. Harlow E, Whyte P, Franza R and Schley C. (1986). Mol. Cell. Biol., 6, 1579-1589.
15. Higashino F, Pipas JM and Shenk T. (1998). Proc. Natl. Acad. Sci. USA, 95, 15683-15687.
16. Huang DC and Strasser A. (2000). Cell, 103, 839-842.
17. Ishida S, Yamashita Y, Nakaya U and Tokino T. (2000). Jpn. J. Cancer Res., 91, 174-180.
18. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F and Caput D. (1997). Cell, 90, 809-819.
19. Kim JY, Cho JJ, Ha J and Park JH. (2002). Arch. Biochem. Biophys., 398, 147-152.
20. Kubasiak LA, Hernandez OM, Bishopric NH and Webster KA. (2002). Proc. Natl. Acad. Sci. USA, 99, 12825-12830.
21. Marton MJ, Baim SB, Ornelles DA and Shenk T. (1990). J. Virol., 64, 2345-2359.
22. Miyashita T and Reed JC. (1995). Cell, 80, 293-239.
23. Moore M, Horikoshi N and Shenk T. (1996). Proc. Natl. Acad. Sci. USA, 93, 11295-11301.
24. Nakano K and Vousden KH. (2001). Mol. Cell, 7, 683-694.
25. Nevels M, Rubenwolf S, Spruss T, Wolf H and Dobner T. (1997). Proc. Natl. Acad. Sci. USA, 94, 1206-1211.
26. Nevels M, Rubenwolf S, Spruss T, Wolf H and Dobner T. (2000). J. Virol., 14, 5168-5181.
27. Nevels M, Spruss T, Wolf H and Dobner T. (1998). Oncogene, 18, 9-17.
28. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T and Tanaka N. (2000). Science, 288, 1053-1058.
29. Orlando JS and Ornelles DA. (1999). J. Virol., 73, 4600-4610.
30. Querido E, Blanchette P, Yan Q, Kamura T, Morrison M, Boivin D, Kaelin WG, Conaway RC, Conaway JW and Branton PE. (2001). Genes Dev., 15, 3104-3117.
31. Querido E, Marcellus RC, Lai A, Charbnneau R, Teodoro JG, Ketner G and Branton PE. (1997). J. Virol., 71, 3788-3798.
32. Ray R, Chen G, Vande Velde C, Cizeau J, Park JH, Reed JC, Giets RD and Greenberg AH. (2000). J. Biol. Chem., 275, 1439-1448.
33. Reed JC. (1995). J. Cell. Biol., 124, 1-6.
34. Sarnow P, Hearing P, Anderson CW, Halbert DN, Shenk T and Levine AJ. (1984). J. Virol., 49, 692-700.
35. Sarnow P, Ho YS, Williams J and Levine AJ. (1982). Cell, 28, 387-394.
36. Steegenga WT, Riteco N, Jochemsen AG, Fallanx FJ and Bos JL. (1998). Oncogene, 16, 349-357.
37. Teodoro JG and Branton PE. (1997). J. Virol., 71, 1739-1746.
38. Tsujimoto Y and Shimizu S. (2000). FEBS Lett., 466, 6-10.
39. Vande Velde C, Cizeau J, Dubik D, Alimonti J, Brown T, Israels S, Hakem R and Greenberg AH. (2000). Mol. Cell. Biol., 20, 5454-5468.
40. Weigel S and Dobbelstein M. (2000). J. Virol., 74, 764-772.
41. Weinberg DH and Ketner G. (1986). J. Virol., 57, 833-838.
42. Yasuda M, Theodrakis P, Subramanian T and Chinnadurai G. (1998). J. Biol. Chem., 273, 12415-12421.
43. Yu J, Zhang L, Hwang PM, Kinzler KW and Vogelstein B. (2001). Mol. Cell, 7, 673-682.